Abstract:OBJECTIVE:Visceral hypersensitivity is highly prevalent in most functional bowel disorders, such as irritable bowel syndrome (IBS), and activation of intestinal mast cells (MC) may play a role because they have been found in close proximity to gastrointestinal mucosal sensory nerve terminals containing neuropeptides and a bi-directional pathway connecting the central nervous system, gut, and MC has been demonstrated. The current study appraised the status of rectal visceral perception, as well as the changes in the MC and substance P (SP) in the intestinal mucosa of patients with IBS.METHODS:The study group comprised 42 patients with IBS and 19 healthy subjects who underwent anorectal manometry and rectal perception thresholds to balloon distension. The MC and the SP-ergic terminals in the mucosa were stained for respective histochemical and immunohistochemical investigations. The results were presented both qualitatively and quantitatively by color image analyzer, based on analysis of the intensity and area of stained fibrils. The structural relationship between the MC and nerve terminals was studied by electron microscopy, using an in situ embedding technique.RESULTS:The anorectal resting pressure, squeezing pressure and relaxation pressure were normal in both groups. The sensation threshold, defecation threshold and pain threshold in diarrhea-predominant IBS and the pain thresholds in constipation-predominant IBS were much lower than in the controls. Rectal compliance decreased in IBS. The number of MC in the terminal ileum, the ileocecal junction and the ascending colon was significantly elevated in IBS (P < 0.01), and the MC showed great variation. A significantly increased concentration of SP was found in the colon of the IBS patients compared with the controls. There was a positive correlation between the profiles of mucosal MC and the SP-ergic terminals, and MC were closely adjacent to SP-ergic terminals in the lamina propria.CONCLUSION:As altered rectal perception is present in almost all patients with IBS, it might be a reliable biological characteristic of the disease. Alterations in the MC and SP of the intestinal mucosa may be important factors in visceral hypersensitivity.

Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome

Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice

The Expression of Protease-Activated Receptor 2 and 4 in the Colon of Irritable Bowel Syndrome Patients

The role of protease activated receptor 2 in visceral sensitivity of irritable bowel syndrome patients

Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome

The expression of protease-activated receptors in colon mucosa tissue of patients with diarrhea-predominant irritable bowel syndrome and its significance

Expression of TRP Channels in Colonic Mucosa of IBS-D Patients and Its Correlation with the Severity of the Disease

Changes of Substance P, Vasoactive Intestinal Peptide and Mast Cell in Colonic Mucosa of Patients with Irritable Bowel Syndrome

Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2

Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea

Changes of vasoactive intestinal polypeptide, calcitonin gene-related peptide and mast cell in irritable bowel syndrome

Expression of proteinase activated receptor-2 in intestinal mucosa of patients with ulcerative colitis

Study of Visceral Hypersensitivity in Irritable Bowel Syndrome.

Expression Of G Protein-Coupled Estrogen Receptor In Irritable Bowel Syndrome And Its Clinical Significance

Decreased Expression of Serotonin in the Jejunum and Increased Numbers of Mast Cells in the Terminal Ileum in Patients with Irritable Bowel Syndrome

Increased Production of BDNF in Colonic Epithelial Cells Induced by Fecal Supernatants from Diarrheic IBS Patients

The expression of vasoactive intestinal peptide and mast cells in colonic mucosa of patiens with irritable bowel syndrome

Involvement Of Corticotropon-Relesing Factor And Receptors In Immune Cells In Irritable Bowel Syndrome

Pilot Study of Small Bowel Mucosal Gene Expression in Patients with Irritable Bowel Syndrome with Diarrhea.

Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: A role in pain symptom generation?

[The Changes of Mucosal Mast Cells and Substance P in Patients with Irritable Bowel Syndrome].